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Objective: To evaluate the effect of hydroethanolic extract of yacon on the hypergly-
cemia induced by streptozotocin (STZ) in neonatal rats.
Methods: Wistar rats aged two days old received an intraperitoneal injection of STZ
(160 mg/kg); after seven weeks, glycosuria was determined and animals with glucose
levels above 250 mg/dL were included in the study. Groups of diabetic and non-diabetic
rats were treated orally with yacon extract at a dose of 400 mg/kg/d for 14 d. Tests were
made for phytochemical characterization, glucose tolerance and toxicity.
Results: The results showed that treatment with the extract reduced the glucose levels of
fed diabetic rats and did not change the glucose levels of fasting diabetic and normal rats.
Additionally, also it was observed that treatment with the extract reduced blood glucose
levels of diabetic rats during the oral and intravenous glucose tolerance tests. There was
no change in body weight, liver enzymes or mortality with yacon extract treatment. The
phytochemical screening revealed the presence of caffeic acid, chlorogenic acid, ferulic
acid and gallic acid.
Conclusions: The data suggest that yacon extract reduces hyperglycemia, possibly by
improving insulin sensibility through its phytochemicals constituents (phenolic
compounds).1. Introduction
Diabetes mellitus is a serious chronic disease, and is
considered one of the ﬁve leading causes of death worldwide
[1,2]. This disease is characterized by high blood glucose levels,
caused by a deﬁciency in insulin secretion and/or a resistance to
insulin action [3].
Diabetes mellitus can be classiﬁed as diabetes mellitus type 1
(DM1) and diabetes mellitus type 2 (DM2). DM1 is character-
ized by an absolute deﬁciency of insulin secretion associated
with the autoimmune destruction of pancreatic b cells. DM2,
which accounts for over 90% of cases, is caused by acombination of resistance to insulin action and impaired secre-
tion of this hormone [4]. In DM2, muscle and adipose tissue are
resistant to insulin and compensatory insulin secretion is
insufﬁcient to maintain the physiological levels of glucose [5].
Drug therapy for diabetes is conventionally performed using
oral hypoglycemic agents (such as metformin, glyburide,
chlorpropamide, and others) and insulin. However, based on
recommendations of the World Health Organization [6], anti-
diabetic agents derived from plants are an important alterna-
tive for the treatment of disease. In recent years, interest in using
natural products for pharmacological purposes has increased
greatly as a form of complementary therapy. Particularly in the
case of diabetes, studies have shown that plant extracts are
effective in reducing blood glucose, causing fewer adverse ef-
fects compared to traditional anti-diabetic agents [7,8].
The yacon plant is native of the Andes, the family Asteraceae
(Compositae), the species Smallanthus sonchifolius
(S. sonchifolius). Aybar et al. [9] demonstrated the anti-
hyperglycemic effect of aqueous extracts obtained from leavesrticle under the CC BY-NC-ND license (http://
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glucose tolerance or diabetic. Recent studies by our group
showed that treatment with extracts of yacon for 14 d reduced
blood glucose levels in diabetic animals (DM1) and that this
effect was not related to reduced food intake or interference of
the extract on the intestinal absorption of carbohydrates [10]. In
addition, other studies have shown that the butanol,
chloroform and methanol fractions of yacon leaves extracts
also reduced the blood glucose of diabetic rats [11]. The aim of
this study was to evaluate whether the hydroethanolic extract
of yacon changes the hyperglycemia induced by streptozotocin
(STZ) in neonatal rats.
2. Material and methods
2.1. Preparation of hydroethanolic extract of yacon
The extracts were prepared from S. sonchifolius leaves ac-
quired from Takashi Kakihara Ltda., Capão Bonito – São Paulo,
Brazil. A voucher specimen was deposited at the Herbarium of
the State University of Maringa´ under number HUEM 13021.
Hydroethanolic extract from S. sonchifolius was obtained from
10% (w/w) solution with 70% ethanol, stirred mechanically for
5 h. Next, the extract was ﬁltered, slowly evaporated to remove
the solvent, lyophilized, and stored at −20 C. For the assays, the
hydroethanolic extract of S. sonchifolius (hydroethanolic extract
of yacon) was suspended in water immediately before use.
2.2. Chromatographic procedures
The hydroethanolic extract of yacon was fractionated by
means of high performance liquid chromatography (HPLC). The
HPLC system (Shimadzu®, Japan) consisted of a system
controller (SCL-10AVP), two pumps (model LC10ADVP), a
column oven (model CTO-10AVP), and a UV–vis detector
(model SPD-10AVP). A reversed-phase column C18HRC-ODS
(Shimadzu®, Japan), protected with a pre-column GHRC-ODS
(Shimadzu®, Japan), was used. The injection volume was 20 ml.
The mobile phase was methanol/acetic acid 4% (3/7), with the
ﬂow 1 ml/min and temperature of 35 C. Spectrophotometric
monitoring was performed at 254 nm. The identiﬁcation of each
compound was based on a comparison of the retention time of
external standards.
2.3. Induction of diabetes
Diabetes was induced in male newborn (2 d old) Wistar rats
injected intraperitoneally with STZ (160 mg/kg) dissolved in
citrate buffer (10 mM; pH 4.5). The animals were maintained at a
controlled temperature (±22 C) and a 12-h-dark-light cycle, with
balanced food and free access to water. The protocol for these
experiments was approved by the Committee on Experimental
Animal Ethics of the State University of Maringa´. Seven weeks
later, the diabetic state was conﬁrmed by urine glucose level
determination and animals with glycosuria above 250 mg/dL
were included in the study.
2.4. Treatment of diabetic and normal rats
The hydroethanolic extract of yacon (400 mg/kg body
weight) or water was administered by the oral route (gavage), ina single daily dose, in diabetic and normal rats for 14 d. The
body weights of rats were evaluated daily, during experimental
period.
2.5. Effect of hydroethanolic extract of yacon on
glycemia and the activity of plasma phosphatase and
transaminases
Blood samples were collected from the inferior vena cava
blood in heparinized tubes, and centrifuged at 1100 ×g for
15 min, and the plasma was separated. The concentration of
glucose was determined in aliquots of plasma (10 ml), using the
glucose oxidase colorimetric enzymatic method (Gold Ana-
lisa®). The activity of alkaline phosphatase (ALP), aspartate
aminotransferase (AST), and alanine aminotransferase (ALT)
was determined in the plasma of diabetic and normal rats, by the
colorimetric-kinetic method, using a commercial kit (Gold
Analisa®).
2.6. Oral glucose tolerance test (OGTT)
After 14 d of treatment with the hydroethanolic extract of
yacon, the animals under fasting for 15 h received an oral
glucose solution (1 g of 50% glucose solution/kg body weight).
At zero, 15 and 30 min after the administration of glucose so-
lution, blood samples were collected from the tails of animals to
determine the concentration of plasma glucose using the glucose
oxidase colorimetric enzymatic method (Gold Analisa®).
2.7. Intravenous glucose tolerance test (EGTT)
After 14 d of treatment with the hydroethanolic extract of
yacon, the animals under fasting for 15 h received intrave-
nous glucose solution (0.5 g of 50% glucose solution/kg
body weight). At zero, 5, 10, 20, 30 and 60 min after glucose
infusion, blood samples were collected from the inferior vena
cava of the animals and conditioned in heparinized tubes.
The plasma glucose concentration was determined by
glucose oxidase colorimetric enzymatic method (Gold
Analisa®).
2.8. Statistical analysis
The statistical analysis of the data was done using GraphPad
Prism® (GraphPad Software Inc., Microsoft Corp.). Results were
expressed as mean ± standard error of the mean and analyzed
using analysis of variance (ANOVA followed by Tukey's test)
for multiple comparisons. The area under the curve was calcu-
lated using the trapezoidal rule. P < 0.05 was considered the
criterion for signiﬁcance.
3. Results
3.1. Chemical constituents of hydroethanolic extract of
yacon
The HPLC method using a C18 column was commonly used
to assess the presence of polyphenols in plant extracts. Four
phenolic acids were identiﬁed by comparing the retention time
of external standards: caffeic acid, chlorogenic acid, ferulic acid
and gallic acid (Figure 1).
Figure 3. Effect of treatment with hydroethanolic extract of S. sonchifolius
leaves (yacon extract).
(A) Effect on blood glucose in rats after oral glucose load (1 g/kg body
weight). (B) The data were presented as the area under the curve. aP < 0.05,
compared with normal rats (N); bP < 0.05, compared with diabetic animals
(D) (ANOVA followed by Tukey's test).
Figure 1. Chromatograms of the hydroethanolic extract of S. sonchifolius
leaves (yacon extract) and injected standards detected by HPLC at 254 nm.
(A) gallic acid (6.2), (B) chlorogenic acid (14.4), (C) caffeic acid (15.4), (D)
ferulic acid (17.9).
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glycemia in diabetic and normal rats
The effect of yacon on glycemia in diabetic and normal rats
in the fed state and in fasting state is shown in Figure 2A and B,
respectively. The glycemia of the diabetic rats in the fed state
[(162.50 ± 7.29) mg/dL] was higher than in normal rats
[(128.90 ± 2.91) mg/dL]. The treatment with yacon did not alter
the glycemia of normal rats [(116.60 ± 3.56) mg/dL] but
signiﬁcantly reduced the glycemia of the diabetic rats in the fed
state by 22.8% [(125.50 ± 3.99) mg/dL]. However, the treatment
of normal and diabetic rats in the fasting state with the extract
did not change the glucose levels.
3.3. Effect of hydroethanolic extract of yacon on
transient hyperglycemia induced by oral administration
of glucose (OGTT)
The glycemia of diabetic and normal rats under fasting was
signiﬁcantly increased 15 and 30 min after glucose load
[N0 = (70.7 ± 5.5) mg/dL; N15 = (121.1 ± 6.3) mg/dL;
N30 = (131.0 ± 11.5) mg/dL; D0 = (93.9 ± 4.2) mg/dL;
D15 = (184.7 ± 8.6) mg/dL and D30 = (206.2 ± 11.9) mg/dL].
The treatment of normal rats with the extract did not alter the
plasma glucose concentration; however, there was a reduction in
glucose concentration in diabetic rats at 15 and 30 min after
glucose loading [DY15 = (147.0 ± 9.2) mg/dL;
DY30 = (156.8 ± 8.6) mg/dL]. The results are shown inFigure 2. Effect of treatment with hydroethanolic extract of S. sonchifolius
leaves (yacon extract) on glycemia in fed rats (A) and fasting rats (B).
aP < 0.05, compared with normal rats (N); bP < 0.05, compared with
diabetic animals (D) (ANOVA followed by Tukey's test).Figure 3A, and these results are demonstrated by area under the
curve in Figure 3B.
3.4. Effect of hydroethanolic extract of yacon on
transient hyperglycemia induced by intravenous
administration of glucose (ETTG)
Figure 4A and B shows changes in plasma glucose levels
during ETTG in diabetic and normal rats under fasting. In normal
rats, glucose levels were signiﬁcantly increased 5 min after the
glucose load and gradually reduced over the 60 min experiment
[N0 = (105.7 ± 6.4) mg/dL; N5 = (298.3 ± 10.7) mg/dL;
N10 = (247.5 ± 12.0) mg/dL; N20 = (195.5 ± 19.5) mg/dL;
N30 = (158.8 ± 15.8) mg/dL and N60 = (130.6 ± 10.5) mg/dL].
On the other hand, the glycemia of diabetic rats remained
increased throughout the period [D0 = (145.3 ± 5.7) mg/dL;
D5 = (357.6 ± 12.2) mg/dL; D10 = (322.9 ± 9.5) mg/dL;
D20 = (292.6 ± 9.9) mg/dL; D30 = (275.3 ± 8.5) mg/dL and
D60 = (254.4 ± 12.8) mg/dL]. The glycemia in diabetic rats
treated with the yacon extract was signiﬁcantly reduced when
compared to diabetic control of glucose at 10, 20, 30 and 60 min
after glucose loading [DY10 = (303.8 ± 7.1) mg/dL;
DY20 = (268.8 ± 8.8) mg/dL; DY30 = (248.3 ± 9.8) mg/dL and
DY60 = (214.6 ± 8.7) mg/dL]. The treatment with yacon extract
did not change the blood glucose of normal animals.
3.5. Effect of hydroethanolic extract of yacon on body
weight and liver injury of diabetic and normal rats
The treatment of diabetic and normal animals with yacon
extract did not change the body weight, without any signiﬁcantFigure 4. Effect of hydroethanolic extract of S. sonchifolius leaves (yacon
extract) on serum glucose in rats after intravenous glucose overload (0.5 g/
kg body weight).
(A) Glycemia; (B) The data were presented as the area under the curve.
aP < 0.05, compared with normal rats (N); bP < 0.05, compared with
diabetic animals (D) (ANOVA followed by Tukey's test).
Table 1
Effect of oral treatment with the hydroethanolic extract of yacon (Y-
400 mg/kg/d) for 14 d, on AST, ALT, and ALP.
Enzymatic activity (U/L) AST ALT ALP
N 84.2 ± 4.2 41.3 ± 2.7 122.5 ± 2.3
NY 85.6 ± 3.6 49.3 ± 2.4 120.3 ± 9.9
D 87.7 ± 3.3 45.8 ± 2.5 132.0 ± 7.3
DY 87.6 ± 3.3 45.0 ± 2.9 131.1 ± 9.0
N, normal rats; NY, normal treated rats; D, diabetic rats; DY, diabetic
treated rats (ANOVA followed by Tukey's test).
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activity of liver enzymes (AST, ALT and ALP) was not
signiﬁcantly increased in the plasma of diabetic and normal rats
treated with yacon extract (Table 1). Mortality was not observed
in the treated groups (data not shown).
4. Discussion
Ethnobotanical studies show that around 800 plants are used
as traditional remedies for the treatment of diabetes due to their
effectiveness, fewer side effects and relatively lower cost [12]; in
this context, the use of leaves and/or yacon roots has shown anti-
hyperglycemic activity [13,14].
Baroni et al. [10] found that the crude extract of yacon leaves
signiﬁcantly reduced blood glucose levels of diabetic rats in the
experimental model induced by STZ. It was also shown that the
hydroethanolic fraction of the extract was able to reduce the
glycogen content of the liver and skeletal muscle, and restored
the activity of glucose 6-phosphate dehydrogenase in type 1 dia-
betic rats [13]. Additionally, Genta et al. [11] also showed that the
methanolic, butanolic and chloroform yacon extract, tested in a
type 1 diabetes model induced by STZ, increased the plasma
levels of insulin, reducing the blood glucose. However, the
above results are associated with a fasting state in experimental
models of DM1, which is different to the results of the present
study in which the effect of the hydroethanolic yacon extract
was observed in the fed state in a newborn STZ-diabetes model.
This experimental model has been widely used as a tool for the
research of compounds with anti-diabetic actions, as well as to
study the mechanism involved in disease, as it exhibits several
phases of DM2, such as impaired glucose tolerance, and mild,
moderate or severe glycemia. It has been reported that blood
glucose changes and chronic hyperglycemia develop in rats that
receive STZ injection on the second day after birth [15–18].
The results of this study demonstrated that the hydroethanolic
extract of yacon (400 mg/kg) signiﬁcantly (P < 0.05) reduced
blood glucose level in fed diabetics rats when compared with the
control rats (normal). To conﬁrm this anti-hyperglycemic effect,
oral and intravenous glucose tolerance tests were conducted,
which can identify insulin sensitivity [8]. Yacon reduced the
blood glucose levels of diabetic rats after glucose loading in
both tests, but did not change the glucose levels in normal
rats. These results are possibly due to the reduction of insulin
resistance. An insulin-resistant state is one of the biggest risk
factors for developing diabetes [19]; therefore, reducing insulin
resistance can positively contribute to the control of diabetes
mellitus complications.
The improvement of glycemia using the hydroethanolic
extract of yacon may be due to its phytochemical constitution.
Genta et al. [11] showed that the hypoglycemic effect of
butanolic yacon extract was attributed to the presence ofphenolic compounds such as caffeic acid and chlorogenic acid.
Other authors have also shown that plants rich in phenolic
compounds, ﬂavonoids, terpenoids and coumarin have
potential hypoglycemic effects [20–23]. Among these
compounds, caffeic acid in particular is associated with
reduced blood glucose [24] and chlorogenic acid to recover
glucose intolerance and insulin resistance [25]. Additionally, it
was also shown that the gallic acid increases plasma insulin
[26]. Our results showed that the phytochemical analysis of the
hydroethanolic extract yacon identiﬁed the presence of
phenolic compounds such as caffeic acid, ferulic acid, gallic
acid and chlorogenic acid, which may possibly contribute to
the anti-hyperglycemic effect observed.
Interestingly, treatment with hydroalcoholic extract of yacon
for 14 d (400 mg/kg/d) did not cause liver damage and mortality,
and also did not affect the weight gain of animals. The non-
toxicity effect was also observed in the study by Oliveira et al.
[27], who showed that polar yacon extract (rich in phenolic
compounds such as chlorogenic acid, caffeic acid and
coumarin compounds) produced toxicity only at high doses
(1000 mg/kg) following prolonged treatment (90 d). The
authors suggest that the polar extract is safe for oral
administration since it presents low or absent sesquiterpene
lactones.
Among the strategies for diabetes control are normalization
of glucose-induced insulin secretion and restoring glucose
transport into insulin sensitive tissues. Our results showed that
the hydroethanolic extract of yacon has the potential ability to
control hyperglycemia probably through one or a combination of
the above mechanisms. However, further work should be carried
out to determine the toxicity proﬁle, isolate the bioactive com-
pound(s) in the plant and determine the exact mechanism(s) of
action.
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